Signaling pathways
-
BA6057 IRAK4-IN-1Summary: IRAK4-IN-1 is an interleukin-1 receptor-associated kinase 4 inhibitor. -
BA6058 PF-06426779Summary: PF-06426779 is a potent and selective inhibitor of interleukin-1 receptor-related kinase 4.
-
BA6059 KTX-951Summary: KTX-951 is a targeted degradation (=18nM).
-
BA6060 GLPG2534Summary: GLPG2534 is a selective inhibitor with oral activity.
-
BA6061 IRAK4-IN-21Summary: IRAK4-IN-21 (compound 17) is an orally effective and selective potent inhibitor.
-
BA6062 IRAK4-IN-6Summary: IRAK4-IN-6 is an orally active, selective inhibitor.
-
BA6063 HS271Summary: HS271 is a potent, orally effective, selective inhibitor.
-
BA6064 IRAK4-IN-22Summary: IRAK4-IN-22 (compound 18) is an orally effective and selective potent inhibitor.
-
BA6065 IRAK4-IN-14Summary: IRAK4-IN-14 is a potent and selective inhibitor with oral activity.
-
BA6066 LarotinibSummary: Larotinib is a potent, broad-spectrum, orally active tyrosine kinase inhibitor (TKI).